| Synonyms: | |
| Status: | Phase 1 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | CNI3N6QR71 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Leukocyte immunoglobulin-like receptor subfamily A member 4 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lupus Erythematosus, Discoid | 2 | D008179 | ClinicalTrials |
| Myositis | 2 | D009220 | ClinicalTrials |
| Lupus Nephritis | 2 | D008181 | ClinicalTrials |
| Alopecia Areata | 2 | D000506 | ClinicalTrials |
| Lupus Erythematosus, Systemic | 2 | D008180 | ClinicalTrials |
| Acute Lung Injury | 1 | D055371 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4594330 |
| FDA SRS | CNI3N6QR71 |
CONTENTS